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Abstract
Pregnant women have abundant natural killer (NK) cells in their placenta, and NK cell function is regulated by
polymorphisms of killer cell immunoglobulin-like receptors (KIRs). Previous studies report different roles of NK cells in the
immune responses to placental malaria (PM) and human immunodeficiency virus (HIV-1) infections. Given these references,
the aim of this study was to determine the association between KIR gene content polymorphism and PM infection in
pregnant women of known HIV-1 status. Sixteen genes in the KIR family were analyzed in 688 pregnant Kenyan women.
Gene content polymorphisms were assessed in relation to PM in HIV-1 negative and HIV-1 positive women, respectively.
Results showed that in HIV-1 negative women, the presence of the individual genes KIR2DL1 and KIR2DL3 increased the
odds of having PM, and the KIR2DL2/KIR2DL2 homozygotes were associated with protection from PM. However, the reverse
relationship was observed in HIV-1 positive women, where the presence of individual KIR2DL3 was associated with
protection from PM, and KIR2DL2/KIR2DL2 homozygotes increased the odds for susceptibility to PM. Further analysis of the
HIV-1 positive women stratified by CD4 counts showed that this reverse association between KIR genes and PM remained
only in the individuals with high CD4 cell counts but not in those with low CD4 cell counts. Collectively, these results
suggest that inhibitory KIR2DL2 and KIR2DL3, which are alleles of the same locus, play a role in the inverse effects on PM
and PM/HIV co-infection and the effect of KIR genes on PM in HIV positive women is dependent on high CD4 cell counts. In
addition, analysis of linkage disequilibrium (LD) of the PM relevant KIR genes showed strong LD in women without PM
regardless of their HIV status while LD was broken in those with PM, indicating possible selection pressure by malaria
infection on the KIR genes.
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Introduction
In sub-Saharan Africa, it is estimated that 32 million pregnant
women are at risk for Plasmodium falciparum infection annually [1].
The placenta, in particular, is highly susceptible to the infection
and malaria parasite sequesters in vascular spaces, resulting in
local inflammation [2]. Parity-dependent malarial immunity is
acquired over consecutive pregnancies protecting multigravid
women against the adverse effect of pregnancy-associated malaria,
and as a consequence, in high transmission areas susceptibility to
malaria decreases with increasing gravidity, whereas in areas of
low endemicity, this trend is not as evident. The public health
consequences of malaria in pregnancy also vary by transmission
intensity: maternal illness, preterm births and fetal loss predom-
inate in low transmission settings whereas maternal anemia, fetal
growth restriction resulting in low birth weight and subsequent
increased infant mortality are commonly seen in high transmission
areas [3,4,5]. HIV-1 infection in women of reproductive age is
another major public health problem and often coexists with
malaria in pregnant women in sub-Saharan Africa [6]. HIV
complicates the adverse consequences of placental malaria (PM)
by increasing risk of infection, parasite densities and severity of the
disease [7,8] and by impairing the response to anti-malarial
therapy [9]. On the other hand, malaria infection in pregnant
women increases HIV-1 viral load [10], but the effect on perinatal
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studies addressed whether PM enhanced MTCT and all were
conducted prior to the widespread introduction of antiretrovirals
(ARVs) with conflicting conclusions [11,12,13,14,15,16], showing
increased MTCT in two studies in Uganda [11,15], no effect in
two other studies at the Kenya Coast [13,14], and a significant
protective effect in Mozambique and western Kenya [12,16].
Pregnant women have abundant Natural Killer (NK) cells in the
decidua of placenta. NK cells function by cell cytolysis or by
cytokine production, and their functions have been implicated in
the process of placentation and as first-line innate immune defense
to infection during pregnancy [17]. Previous immunological
studies have shown that increased IFN-c expressing NK cells in
the placenta were associated with a reduced risk of PM infection
regardless of gravidity [18], and that HIV-1 infection could impair
their ability to control PM, in part, by loss of IFN-c production in
placenta [19]. NK cells have also been associated with protection
from HIV infection [20]; however high HIV viral loads cause
expansion of functional deficient NK cells [21,22]. These results
suggest that NK cell related immunity is involved in both malaria
infection during pregnancy and HIV infection, and malaria co-
infection with HIV could have the potential to change NK cell
mediated defense to both diseases.
Killer immunoglobulin (Ig)-like receptors (KIRs) are surface
receptors expressed on NK cells, which modulate NK cell
functions in response to changes caused by stress and infection
[23]. The human KIR family comprises of 17 individual KIR
genes located on chromosome 19q13.4, and nomenclature of the
KIR genes is based on structural and functional characteristics
[24]. A KIR with two extracellular Ig domains and short
intracytoplasmic tail is named KIR2DS with a given number as
a suffix, such as KIR2DS2 or KIR2SD4. A KIR with three
extracellular Ig domains and long intracytoplasmic tail is named
KIR3DL with a given number as a suffix, for example KIR3DL1
and KIR3DL2. Functionally, KIRs with short intracytoplasmic
tails (S) activate NK cells and those with long intracytoplasmic tails
(L) inhibit NK cells [24]. Some KIR genes have strong linkage
disequilibrium (LD), and are thus usually inherited together [25].
KIRs are the second most polymorphic family in the mammalian
genome after the major histocompatibility complex (MHC), and
their polymorphisms differ between individuals mainly at three
levels: 1) gene content polymorphism of KIR family; 2) allelic
diversity of individual KIR genes; and 3) variation in binding
specificity of individual KIR to HLA class I ligands [26]. This
extreme polymorphism has made the KIR gene family a
compelling genetic target for disease association studies, particu-
larly for infectious diseases in which NK cells are involved [27,28].
During pregnancy, NK cells in the decidua of human placenta
mainly expresses inhibitory KIR2DL1, KIR2DL2, and
KIR2DL3, dual functional (inhibitory/activating) KIR2DL4 and
activating KIR2DS1 with skewed distribution of HLA-C ligand in
the trophoblast [17,29,30]. The NK cell functions in the placenta
are in part modulated by the balance of inhibitory and activating
signals from KIRs. The NK cell functions predominantly
mediated by cytokine production in the placenta regulate
pregnancy outcomes while the NK cell functions presumably
mediated by cytolysis and cytokine production are essential in the
defense against infections [29,30,31]. Therefore, KIR gene locus
profiles in the placenta are essentially shaped by a combination of
pregnancy success and pathogen defense during pregnancy
Polymorphisms of KIRs have been studied in both non-
infectious and infectious diseases [32]. In pregnancy, polymor-
phisms of KIR gene content coupled with variation of HLA
ligands have been associated with recurrent miscarriages [33,34]
and predisposition to pre-eclampsia [35]. Break in strong LD
between KIR genes has also been found in leukemia patients [36].
The outcomes of several viral infections such as HIV/AIDS, HCV
and HBV have also been related with KIR gene content
polymorphism and/or allele diversity along with HLA ligand
variation [37,38,39,40]. So far, few studies have addressed the role
of KIR gene polymorphism in malaria. One such study involved
analysis of KIR genotypes and in vitro NK cell response to malaria
parasite in non-immune donors and reported a relationship
between inhibitory KIR3DL2*002 allele and high NK cell IFN-c
response [41]. Another small-scale field-based study conducted in
no-pregnant adults in Solomon Island (n=77) found that malaria
positive individuals had a high frequency of KIR3DL1/KIR3DS1
heterozygosity in combination with non-deleted KIR2DS4 allelic
variant [42]. The results from these limited studies suggest that
KIRs are important candidate genes in host resistance to malaria
infection.
Given the abundance of NK cells in the placentas of pregnant
women, the biological relevance of the different roles of NK cells
in the hosts’ immune responses to PM and HIV infections, the role
of KIR polymorphism in regulating NK function and the
involvement of KIRs in malaria infection in non-pregnant women,
the aim of this study was to determine whether KIR gene content
polymorphism was associated with protection or susceptibility to
PM infection in pregnant women of known HIV-1 status. Here,
we provide the first evidence that 1) the KIR gene content
polymorphism is associated with PM infection, 2) this association is
affected by the HIV status of the pregnant women, and 3) the
effect of KIR gene content polymorphism on PM infection in the
HIV positive women is dependent on high CD4 cell counts. In
addition, analysis of linkage disequilibrium (LD) of the PM
relevant KIR genes further suggested malaria infection has a
selection pressure on the genes.
Materials and Methods
Ethics Statement
Written informed consent was obtained from women at time of
enrollment. Study methods were approved by the Kenya Medical
Research Institute Ethical Review Committee, Nairobi, Kenya
and the Institutional Review Board of the Centers for Disease
Control and Prevention, Atlanta, GA, USA.
Study Site and Population
The present study was integrated into an epidemiologic
investigation of the relationship between PM and MTCT of
HIV-1 (the ‘VT project’) carried out in western Kenya between
1996 and 2001. Methods for the epidemiological study have been
described in detail elsewhere [43]. Briefly, at the time of the study,
the transmission of malaria was intense and perennial, and P.
falciparum accounted for about 98% of malarial infections. The
residents in this area are predominantly of Luo ethnic group.
Women with singleton uncomplicated pregnancies of at least 32
weeks gestation were enrolled if they had no known underlying
chronic illnesses. Information on reproductive history, socio-
demographics, malaria treatment, and heath/clinical status was
collected at enrollment and delivery respectively. Blood samples
were collected at enrollment, delivery and 1 month postpartum for
malaria diagnosis, HB level determination, HIV-1 diagnosis, HIV-
1 viral load and/or CD4 counts. In the main VT study,
enrollment priority was given to HIV-positive women, and within
HIV-negative women enrollment priority was given to the women
with PM. A total of 269 HIV-negative and 829 HIV-positive
pregnant women were enrolled in the main VT study. For this
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478 HIV-positive pregnant women were tested for KIR gene
content polymorphisms. Sample selection for this nested genetic
study was based on two criteria: 1) women who had the diagnostic
results for both PM and HIV-1 and the information on treatment
for malaria during the third trimester of pregnancy, and 2)
availability of samples for DNA purification among these women.
Laboratory Procedures
Malaria and anemia diagnosis. PM was assessed on blood
samples obtained from a shallow incision on the maternal side of
the placenta. Thick smears made from peripheral and placental
blood were examined by microscopy. The number of asexual
parasites/300 leukocytes was counted. Parasite density was
estimated on the assumption of 8000 leukocytes/ml. The presence
of malarial pigment in placental intervillous macrophages was also
recorded. Peripheral blood hemoglobin concentrations (g/dl) were
quantified by use of the HemoCue system (HemoCue).
HIV serology diagnosis, CD4 counts and viral load. A
primary Serostrip HIV-1/2 (Saliva Diagnostic Systems) and a
confirmatory Capillus HIV-1/2 test (Cambridge Diagnostics) were
used to determine maternal HIV status. CD4 cell counts in HIV-
positive women were determined by standard fluorescent-activated
cell-sorting analysis on whole blood (FACScan, Becton Dickinson).
Maternal HIV-1 load was measured by use of the Roche Amplicor
HIV-1 monitor (test version 1.0; Roche Diagnostics).
KIR Genotyping. DNA was extracted from the blood
samples using the QIAamp DNA blood mini kit (Qiagen). KIR
genotyping for 16 KIR genes was carried out using KIRSSO
genotyping test based on the manufacturer instructions (One
Lambda Inc.). Briefly, three PCR products were hybridized with a
panel of beads labeled with KIR specific probes and results were
read for each bead in a separate session on the Luminex 200 IS
(Luminex Corp.). Data was acquired using the IS v2.3 software
(Luminex Corp.), and HLA Fusion Beta software (One Lambda
Inc.) was used to determine the presence or absence of individual
KIR genes. Five positive control DNA samples from the
International Histocompatibility Working Group (IHWG) with
different profiles of KIR gene content were used in all
experiments. In addition, quality assurance was conducted using
another gene-specific method, KIRSSP [44], and the results from
this method matched with that using the KIRSSO commercial kit.
Definitions
Clinical endpoints and definitions. Peripheral parasitemia
was defined as any asexual blood-stage parasites seen by
microscopy on a thick smear. Thick smears were deemed negative
if viewing 100 high-power fields revealed no parasites. PM was
similarly defined. Placentas with malarial pigment in the absence
of parasitemia were classified as negative for PM. Anemia was
defined as a hemoglobin concentration ,11 g/dL and severe
anemia as ,7 g/dL. The malaria-transmission season comprised
the months of April–June and October–December. The variable
‘‘season of third trimester’’ was defined as the women experienced
with malaria transmission season during 3 months before delivery.
Newborns were classified as ‘‘preterm’’ if delivery occurred before
37 weeks gestation. Low birth weight (,2500 g) of newborn was
based on weight measured to the nearest 10 grams within 24 hours
of birth. Gravidity of mothers was stratified into primi-, secundi-,
and multigravid. Maternal HIV-positive status was determined on
the basis of antibodies to HIV-1, detected by 2 rapid serological
tests. Viral loads were categorized as ,1,000, 1000–9999, and
.=10,000 copies/mL of plasma and CD4 cell counts were
compared with cut-offs of 350 and 500 cells/mL.
Definitions for KIR gene content polymorphisms. KIR
gene content polymorphisms used in this study were defined at four
different levels to explore any possible association with multiple
malaria related outcomes as well as placental malaria/HIV co-
infection. The first level was the presence or absence of 16 individual
KIR genes; 8 inhibiting, 6 activating and 2 pseudogenes [32].
Secondly, based on results of single KIR gene content polymorphism
in relation to PM in this study, reported linkage disequilibrium, and
segregation as alleles, two gene pairs KIR2DL2/KIR2DL3 and
KIR2DS2/KIR2DL2 were used to further assess KIR gene content
polymorphisms. The third level was the conventional classification of
Haplotypes A and B. Haplotype A was defined based on the presence
of 9 KIR genes, KIR3DL3, KIR2DL3, KIR2DL1, KIR2DP1,
KIR3DP1, KIR2DL4, KIR3DL1, KIR2DS4 and KIR3DL2 only,
while all remaining individuals were defined as Haplotype B
[45,46,47]. Fourth, KIR were grouped as previously reported
genotypes AA, AB and BB, where genotype AA included individuals
with KIR3DL3, KIR2DL3, KIR2DL1, KIR2DP1, KIR3DP1,
KIR2DL4, KIR3DL1, KIR2DS4, and KIR3DL2, genotype BB
were individuals who did not have KIR2DL1, KIR2DL3, KIR3DL1
and KIR2DS4, and all the remaining individuals not in AA or BB
were grouped as genotype AB [33]. Lastly, the more polymorphic
haplotype B was further defined into subtypes based on three genes
used above (KIR2DL2, KIR2DL3 and KIR2DS2) which show
selection expression (either exclusivelyor simultaneously). This was to
increase the resolution on haplotype B as previous studies show
conflicting content polymorphisms in the gene combinations. Some
reports show KIR2DL2/KIR2DL3 as alleles of the same locus,
KIR2DS2 always paired with 2DL2, and 2DS2/2DL2 both
negatively associated with 2DL3 [25,44,46,48]. However, others
report that the relationships among the three genes are not exclusive
[45,49,50]. In this study, subtypes B were defined as: B1 is the
presence of KIR2DL3 with absence of KIR2DS2 and KIR2DL2; B2
is the presence of KIR2DL2 with absence of KIR2DL3 regardless of
KIR2DS2; B3 is the presence of all three KIRs; and B4 is the
presence of KIR2DL3 and presence of either KIR2DL2 or
KIR2DS2.
Linkage disequilibrium (LD). Linkage disequilibrium (LD)
is a measure of non-random association of alleles at two loci [51].
LD was used in this study to assess the genetic association between
KIR gene pairs (KIR2DL1, KIR2DL2, KIR2DL3, and
KIR2DS2) relevant to PM in HIV-1 negative and positive
pregnant women respectively. The computation of the LD [52]
is based on the presence and absence of these PM-related genes.
Positive LD is defined as when a gene pair is either present or
absent together, while negative LD is when either one of the gene
pair is present in the absence of the other.
Statistical Analysis
Because of the stratified enrollment in the main epidemiological
study, all analyses were stratified a priori by the mother’s HIV
status. PM was the primary outcome of interest. Parasite density
(log transformed), anemia in the 3
rd trimester, preterm delivery,
and low birth weight were secondary outcomes. Associations
between mother and infant characteristics and the primary
outcome variable PM were first examined using the Pearson
exact chi-square test for the categorical variables and the Wilcoxon
rank sum test for continuous variables.
The associations between KIR gene content polymorphisms
and PM were examined using univariable and multivariable
logistic regression models. KIR categories with the highest
frequencies were used as reference groups for analyses involving
gene pairs, genotypes, haplotypes, and subtypes B. For individual
genes, the reference groups consisted of women without the
Association of KIRs with PM and PM/HIV Coinfection
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antimalarial use during the third trimester, and predominant third
trimester season based on their significance in preliminary analyses
as well as to biological plausibility and prior knowledge. Similar
analyses were performed for the secondary outcomes parasite
density, anemia, pre-term delivery, and low birth weight.
Multivariable analysis of variance (ANOVA) was used for the
log transformed parasite density outcome, controlling for the
variables mentioned above.
In HIV-1 positive women, the effects of CD4 cell counts and viral
load on the association between KIR gene content polymorphisms
and PM were assessed by allowing for interaction between KIR
gene content polymorphisms and CD4 cell counts and viral load
groups. Women with ,350 cells/ml were classified as having low
CD4 cell counts, and women with $10,000 copies/ml were
classified as having high viral load. CD4 cell count and viral load
interactions were included in separate models, and multivariable
models controlled for the factors listed above.
The method of Benjamini and Hochberg [53] was used to correct
for multiple comparisons in the regression analysis by controlling the
false discovery rate (FDR) and the cut-off was set at 0.05. The FDR
was controlled separately for three groups of models: single gene
models, gene pair models, and models for haplotype, genotype, and
subtype B. Within each group, the FDR was controlled indepen-
dently for models for HIV-1 positive and HIV-1 negative mothers.
Uncorrected P-values are given in all tables, with ‘‘*’’ denoting those
tests which were significant (at a=0.05) before correcting for multiple
comparisons but not after, and with ‘‘**’’ denoting those tests that
remained significant after multiplecomparison adjustments. Analyses
were performed using SAS version 9.2.
Arlequin was used to calculate the LD values (D, and D9) between
four PM-relevant KIR genes (KIR2DL1, KIR2DL2, KIR2DL3
and KIR2DS2) using pair-wise test based on the presence or
absence of the respective genes [52]. The pair-wise test was not
possible to conduct if one gene is monomorphic (all presence or all
absence among individuals). LD classical coefficient (D) measuring
deviation from random association between the gene pairs was
expressed as D=Pij- Pi Pj, where Pi and Pj are gene frequencies at
loci i and j. Taking into consideration the role of gene frequencies in
the classical LD coefficient D,aD9 was given by standardizing D
with the maximum value it can have (D9=D/Dmax) [54]. The
statistical significance of both positive and negative LD values was
assessed by Fisher exact test, and corrected using Bonferroni
adjustment, with LD being significant at p,0.002.
Results
Characteristics of women by PM status
The clinical and demographic characteristics of the study
participants are shown in Table 1. In HIV-1 negative women, PM
infection was significantly associated with younger maternal age,
primigravidity, transmission season, and semi urban residence.
Similarly, young age and first pregnancy were risk factors for PM
among HIV-1 positive individuals. A history of antimalarial
treatment in the third trimester was protective against PM among
HIV-1 positive women, but not among HIV-1 negative women.
Among HIV-1 positive women, there was no significant difference
in the maternal CD4 cell counts and HIV-1 load between PM+
and PM2 mothers. Placental malaria was associated with
maternal peripheral malaria, malaria pigment in the placenta,
and a higher risk of delivering low birth weight newborns.
Association between KIR gene content polymorphisms
and PM infection in HIV-1 negative and HIV-1 positive
women
The first analysis was to test if any individual KIR gene was
associated with PM (Table 2). The framework genes KIR3DL2
and KIR3DL3 were present in all samples analyzed and
subsequently excluded from the association analysis. In addition,
the two pseudogenes, KIR2DP1 and KIR3DP1, were also
excluded from the association analysis. Among HIV-1 negative
women, individuals with KIR2DL1 and KIR2DL3 were more
likely to have PM (OR=15.45, 95% CI=.2.05, p=0.006**, and
OR=5.03, 95% CI=1.63–15.54, p=0.005** respectively). In
contrast, in HIV-1 positive women, the presence of only
KIR2DL3, but not KIR2DL1, was associated with protection
from PM (OR=0.41, 95% CI=0.24–0.72, p=0.002**).
Secondly, based on the above key finding of the individual gene
KIR2DL3, its segregation as an allele with KIR2DL2, and the
close relationship between KIR2DL2 and KIR2DS2, two KIR
gene pairs, KIR2DL2/KIR2DL3 and KIR2DS2/KIR2DL2,
were assessed in relation to PM (Table 2). For the first gene pair,
the highest proportions of women were either KIR2DL2/
KIR2DL3 heterozygotes or KIR2DL3/KIR2DL3 homozygotes
while KIR2DL2/KIR2DL2 homozygotes comprised a lower
proportion in both HIV-1 positive and negative women
(Table 2). In HIV-1 negative women, the KIR2DL2/KIR2DL2
homozygotes were less likely to have PM (OR=0.21, 95%
CI=0.07–0.67, p=0.008**). In contrast, the reverse relationship
was observed in HIV-1 positive women, with these individuals
being more likely to have PM (OR=2.37, 95% CI=1.30–4.30,
p=0.005**). For the second gene pair, KIR2DS2/KIR2DL2,
majority of women either had both genes present or absent
together (Table 2). A smaller proportion (approximately 10%) had
KIR2DL2 present and KIR2DS2 absent while the least had only
KIR2DS2 in the absence of KIR2DL2. No association was found
between the KIR2DS2/KIR2DL2 pair and PM in this study.
Lastly, the relationships between KIR haplotypes, subtypes B,
or genotypes and PM were examined (Table 3). There was no
association of KIR haplotypes A and B with PM in both HIV-1
negative and HIV-1 positive women; however, an association
between subtype B2 and PM was observed. A large proportion of
subtype B2 comprised of KIR2DL2/KIR2DL2 homozygous
(90%) in the presence of KIR2DS2 while approximately 10%
had only KIR2DL2/KIR2DL2 and the absence of KIR2DS2. In
HIV-1 negative women, individuals with subtype B2 were less
likely to have PM (OR=0.19, 95% CI=0.06–0.62, p=0.006**).
In contrast, among HIV-1 positive women, subtype B2 was
associated with increased susceptibility to PM (OR=2.18, 95%
CI=1.17–4.06, p=0.014*) (Table 3), although this was not
statistically significant after correcting for multiple comparisons.
This subtype B2 result further confirmed that KIR2DL2/2DL2
homozygous observed in the gene pair comparison (Table 2),
regardless of KIR2DS2, plays a major role in PM and PM/HIV
co-infection. Interestingly, while no association with PM was found
for subtype B3 (KIR2DL2/KIR2DL3 and KIR2DS2 present
together), this subtype B3 group comprised almost a third of all the
individuals in this study (Table 3), an unusual finding when
considering previous reports that showed complete negative or
positive association for the three genes. No association was found
between KIR genotypes AA, AB and BB and PM in this study
(Table 3).
Association of KIRs with PM and PM/HIV Coinfection
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between KIR gene content polymorphism and PM
infection in HIV-1 positive women
Since CD4 cell counts and HIV-1 viral load are important
determinants of HIV progression, we further explored whether
they affected the observed relationship between KIR gene content
polymorphisms (individual KIR2DL3 and KIR2DL2/KIR2DL2
homozygote) and PM. The interaction terms of KIR2DL3 and
KIR2DL2/KIR2DL2 with CD4 cell counts (,350 or $350) and
viral load (,10,000 or $10,000) were not significant but were
retained in models in order to produce individual odds ratios for
CD4 and viral load categories. Associations were evident in
women with CD4 cell counts $350 cells/ml. The presence of
KIR2DL3 alone was associated with protection from PM and
KIR2DL2/KIR2DL2 homozygotes rendered women more sus-
ceptible to PM. These associations remained statistically significant
after correcting for multiple comparisons (Table 4). However,
none of these associations were seen in women with CD4 cell
counts ,350 cells/ml. Among women with lower viral load,
KIR2DL3 was associated with a decreased susceptibility to PM.
The association was not significant after correcting for multiple
comparisons and was not detected in women with higher viral load
(Table 4).
KIR genes LD and PM infection among HIV-1 negative
and HIV-1 positive women
Malaria has a strong selective pressure on human genes [55].
In order to further evaluate the relationship between the KIR
Table 1. Characteristics of HIV-1 negative and HIV-1 positive women, by placental malaria (PM) status.
HIV-1 negative women HIV-1 positive women
Category/Characteristics PM+ (N=116) PM2 (N=93)
a
P PM+ (N=105)
a PM2 (N=374) P
n( % )
a n( % ) n( % ) n( % )
a
Maternal peripheral malaria
Present during third trimester 32/98 (32.7) 9/75 (12.0) 0.002 41/83 (49.4) 36/312 (11.5) ,0.001
Present at delivery 80/113 (70.8) 5/92 (5.4) ,0.001 67/103 (65.1) 13/363 (3.6) ,0.001
Preterm delivery, ,37 weeks 9 (7.8) 6 (6.5) 0.79 12 (11.4) 26/373 (7.0) 0.15
Newborn birth weight, ,2500 g 9 (7.8) 0 (0) 0.005 11 (10.5) 19 (5.1) 0.065
Maternal anemia at third trimester, g/dl
,11 77/98 (78.6) 64/75 (85.3) 0.32 62/82 (75.6) 269/317 (84.9) 0.050
,7 10/98 (10.2) 6/75 (8.0) 0.79 7/82 (8.5) 22/317 (6.9) 0.63
Maternal anemia at delivery, g/dl
,11 74/111 (66.7) 48/90 (53.3) 0.060 67/102 (65.7) 206/361 (57.1) 0.14
,7 9/111 (8.1) 3/90 (3.3) 0.23 12/102 (11.8) 23/361 (6.4) 0.088
Malaria pigment 103 (88.8) 2 (2.2) ,0.001 91 (86.7) 0 (0) ,0.001
Mother’s age, mean years 6 SD 19.563.9 22.564.7 ,0.001 22.064.8 22.764.3 0.016
Gravidity
Primigravid 77 (66.4) 31 (33.3) ,0.001 47 (44.8) 115 (30.8) 0.015
Secundigravid 17 (14.7) 31 (33.3) …… 21 (20.0) 116 (31.0) ……
Multigravid 22 (19.0) 31 (33.3) …… 37 (35.2) 143 (38.2) ……
Antimalarial use, treated during third trimester 27/115 (23.5) 29 (31.2) 0.27 23/104 (22.1) 130/372 (35.0) 0.017
Place of living, semi-urban (vs. urban) 42 (36.2) 21/92 (22.8) 0.048 28/104 (26.9) 94/372 (25.3) 0.80
Predominant season of third trimester, Malaria
transmission season
86 (74.1) 56 (60.2) 0.037 61 (58.1) 208 (55.6) 0.66
Maternal CD4 cell count, cells/ul
,350 …… …… …… 17/93 (18.3) 63/333 (18.9) 1.00
,500 …… …… …… 37/93 (39.8) 127/333 (38.1) 0.81
Median (interquartile range)
b …… …… …… 589 (419–714) 563 (379–818) 0.71
Maternal HIV-1 load, copies/ml
,1000 …… …… …… 36/79 (45.6) 151/299 (50.5) 0.33
1000–9999 …… …… …… 24/79 (30.4) 98/299 (32.8) ……
$10,000 …… …… …… 19/79 (24.1) 50/299 (16.7) ……
Median (interquartile range)
c …… …… …… 1338 (200–9039) 982 (200–5145) 0.26
Note: Shown is percentage of women in given PM and HIV category with specified characteristic unless otherwise noted. P-values are based on Pearson chi-square test
or Wilcoxon test. PM+=placental malaria present, PM2=placental malaria absent.
aIf N differs from number listed, n/N is given.
bN=94 for PM+ and N=335 for PM2.
cN=79 for PM+ and N=299 for PM2.
doi:10.1371/journal.pone.0038617.t001
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KIR2DL3, and KIR2DS2 were calculated in HIV-1 positive
and negative mothers stratified by PM status (Table 5). Among
women who were HIV-1 positive, the gene pairs KIR2DL1/
KIR2DL3 and KIR2DL2/KIR2DS2 were in significant positive
LD, while KIR2DL2/KIR2DL3 and KIR2DL3/KIR2DS2
were in significant negative LD for both women with or without
PM. In contrast, among HIV-1 negative women where LD test
was possible, only KIR2DL2/KIR2DS2 gene pair was in
significant positive LD in women with or without PM. In
addition, distinct differences were observed in LD for some of
KIR gene pairs between PM+ and PM- women regardless of the
HIV status. The gene pairs KIR2DL1/KIR2DL2 and
KIR2DL1/KIR2DS2 (HIV-1 positive), KIR2DL2/KIR2DL3
and KIR2DL3/KIR2DS2 (HIV-1 negative) were in significant
negative LD in women without PM whereas LD was insignif-
icant in all the respective pairs among women with PM. The
significant negative LDs among the women without PM is
similar to that observed in a previous study among the general
African population [49], while the break in LD among the
women with PM is unusual.
Association between KIR gene content polymorphisms
and PM secondary outcomes in HIV-1 negative and HIV-1
positive women
There was no association between the KIR gene content
polymorphisms with any of the PM secondary outcomes in HIV-1
positive women. However, in HIV-1 negative women maternal
anemia was associated with KIR gene content polymorphisms in
which women with subtype B1 (KIR2DS22, KIR2DL22, and
KIR2DL3+) were less likely to have anemia and the association
remained statistically significant after correction for multiple
comparison (data not shown).
Table 2. Adjusted Odds ratios for individual KIR genes and KIR gene combinations in HIV-1 negative and HIV-1 positive women,
outcome placental malaria (PM) status.
HIV-1 negative women HIV-1 positive women
Frequencies Frequencies
PM+
(N=116)
PM2
(N=93) Adjusted OR P
PM+
(N=105)
PM2
(N=374) Adjusted OR P
n (%) n (%) (95% CI) n (%) n (%) (95%CI)
Individual KIR Genes
KIR2DL1 116 (100) 87 (93.6) 15.45(.2.05)
a 0.006** 101 (96.2) 364 (97.3) 0.69 (0.21–2.30) 0.55
KIR2DL2 57 (49.1) 53 (57.0) 0.81 (0.44–1.49) 0.50 61 (58.1) 192 (51.3) 1.23 (0.78–1.92) 0.37
KIR2DL3 111 (95.7) 78 (83.9) 5.03 (1.63–15.54) 0.005** 79 (75.2) 328 (87.7) 0.41 (0.24–0.72) 0.002**
KIR2DL4 116 (100) 92 (98.9) 0.49 (.0.01)
a 1.00 104 (99.1) 372 (99.5) 0.43 (0.04–5.14) 0.51
KIR2DL5 60 (51.7) 57 (61.3) 0.72 (0.39–1.32) 0.29 66 (62.9) 205 (54.8) 1.38 (0.87–2.18) 0.17
KIR2DS1 25 (21.6) 19 (20.4) 1.27 (0.61–2.64) 0.52 15 (14.3) 84 (22.5) 0.59 (0.32–1.08) 0.086
KIR2DS2 46 (39.7) 46 (49.5) 0.75 (0.41–1.36) 0.34 52 (49.5) 161 (43.1) 1.24 (0.80–1.93) 0.34
KIR2DS3 25 (21.6) 23 (24.7) 0.78 (0.39–1.58) 0.49 24 (22.9) 66 (17.7) 1.45 (0.85–2.48) 0.18
KIR2DS4 112 (96.6) 85 (91.4) 2.71 (0.73–10.11) 0.14 100 (95.2) 364 (97.3) 0.52 (0.17–1.60) 0.25
KIR2DS5 43 (37.1) 37 (39.8) 0.99 (0.54–1.83) 0.98 49 (46.7) 167 (44.7) 1.06 (0.68–1.66) 0.79
KIR3DL1 113 (97.4) 89 (95.7) 1.45 (0.29–7.30) 0.65 104 (99.1) 369 (98.7) 1.42 (0.16–12.61) 0.75
KIR3DS1 19 (16.4) 10 (10.8) 1.77 (0.73–4.33) 0.21 9 (8.6) 50 (13.4) 0.63 (0.30–1.35) 0.23
KIR Gene Combinations
KIR2DL2/KIR2DL3
c
2DL2/2DL3 52 (44.8) 38 (40.9) 1.10 (0.58–2.11) 0.77 35 (33.3) 147 (39.4) 0.88 (0.53–1.46) 0.61
2DL2/2DL2 5 (4.3) 15 (16.1) 0.21 (0.07–0.67) 0.008** 26 (24.8) 45 (12.1) 2.37 (1.30–4.30) 0.005**
2DL3/2DL3 59 (50.9) 40 (43.0) 1 ……
b 44 (41.9) 181 (48.5) 1 ……
b
KIR2DS2/KIR2DL2
2/2 58 (50.0) 38 (40.9) 1 ……
b 43 (41.0) 176 (47.1) 1 ……
b
+/+ 45 (38.8) 44 (47.3) 0.75 (0.40,–1.43) 0.86 51 (28.6) 155 (32.4) 0.95 (0.57–1.61) 0.86
+/2 1 (0.9) 2 (2.2) 0.91 (0.08–11.04) 0.94 1 (1.0) 6 (1.6) 0.64 (0.07–5.63) 0.69
2/+ 12 (10.3) 9 (9.7) 1.09(0.39–3.04) 0.87 10 (9.5) 37 (9.9) 1.00 (0.45–2.22) 1.00
Note: PM+=Placental malaria present, PM2=Placental malaria absent. OR=Odds ratio, CI=Confidence interval. P-values are derived from multivariable logistic
regression, controlling for gravidity, anti-malarial use during third trimester, and malaria transmission season. Due to missing covariates in models, 115 PM+ and 93 PM2
used for HIV-1 negative; 104 PM+ and 372 PM2 used for HIV-1 positive. False Discovery Rate (FDR) was used to correct P-values.
‘*’ signifies uncorrected P-value that is ,0.05 but is non-significant after correction.
‘**’signifies uncorrected P-value that is significant after correction.
aDerived using exact logistic regression, median unbiased estimate reported.
bReference group was selected based on the group with highest frequency.
cFor HIV-1+ women, 373 women were PM2.
doi:10.1371/journal.pone.0038617.t002
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outcome placental malaria (PM) status.
HIV-1 negative women HIV-1- positive women
Frequencies Frequencies
PM+ (N=116) PM2 (N=93) Adjusted OR P PM+ (N=105)
PM2
(n=374) Adjusted OR P
n (%) n (%) (95% CI) n (%) n (%) (95%CI)
Haplotypes
A 49 (42.2) 30 (32.3) 1.39 (0.74–2.59) 0.30 36 (34.3) 134 (35.8) 0.97 (0.61–1.54) 0.88
B 67 (57.8) 63 (67.7) 1 ……
b 69 (65.7) 240 (64.2) 1 ……
b
B Subtypes
A 49 (42.2) 30 (32.3) 1 ……
b 36 (34.3) 134 (35.8) 1 ……
b
B1 12 (10.3) 8 (8.6) 0.86 (0.29–2.58) 0.79 9 (8.6) 46 (12.3) 0.80 (0.35–1.82) 0.60
B2 5 (4.3) 15 (16.1) 0.19 (0.06–0.62) 0.006** 26 (24.8) 45 (12.0) 2.18 (1.17–4.06) 0.014*
B3 40 (34.5) 29 (31.2) 0.99 (0.48–2.07) 0.98 29 (27.6) 115 (30.8) 0.86 (0.49–1.50) 0.59
B4 10 (8.6) 11 (11.8) 0.78 (0.28–2.22) 0.64 5 (4.8) 34 (9.1) 0.48 (0.17–1.35) 0.16
Genotypes
AA 46 (39.7) 30 (32.3) 1.17 (0.60–2.30)
a 0.73 34 (32.4) 129 (34.5) 0.94 (0.59–1.51) 0.81
AB 70 (60.3) 61 (65.6) 1 ……
b 70 (66.7) 243 (65.0) 1 ……
b
BB 0 (0) 2 (2.2) 0.29 (0–4.50)
a 0.37 1 (1.0) 2 (0.5) 2.28 (0.19–27.29) 0.52
Note: PM+=Placental malaria present, PM2=Placental malaria absent. OR=Odds ratio, CI=Confidence interval. P-values are derived from multivariable logistic
regression, controlling for gravidity, anti-malarial use during third trimester, and malaria transmission season. Due to missing covariates in models, 115 PM+ and 93 PM2
used for HIV-1 negative; 104 PM+ and 372 PM2 used for HIV-1 positive. False Discovery Rate (FDR) was used to correct P-values.
‘*’signifies uncorrected P-value that is ,0.05 but is non-significant after correction.
‘**’signifies uncorrected P-value that is significant after correction.
aDerived using exact logistic regression, median unbiased estimate reported.
bReference group was selected based on the group with highest frequency.
doi:10.1371/journal.pone.0038617.t003
Table 4. Effect of CD4 cell count and HIV viral load on the relationship of KIR2DL3 and KIR2DL2/KIR2DL2 with PM in HIV-1 infected
women, outcome placental malaria (PM) status.
Parameter, level No. of women PM (%) Adjusted OR P
a
(No. with Gene) (95%CI)
KIR2DL3 Present vs. Absent
CD4 cell count, cells/ml
,350 80 (69) 21.3 0.70 (0.16–3.03) 0.63
$350 346 (296) 22.0 0.35 (0.18–0.67) 0.002**
HIV-1 load, copies/ml
,10,000 309 (267) 19.4 0.44 (0.21–0.93) 0.031*
$10,000 69 (57) 27.5 1.20 (0.28–5.24) 0.80
KIR2DL2/KIR2DL2 2DL2/2DL2 vs. 2DL3/2DL3
CD4 cell count, cells/ml
,350 80 (11) 21.3 1.13 (0.23–5.44) 0.88
$350 345(49) 22.0 2.82 (1.40–5.68) 0.004**
HIV-1 load, copies/ml
,10,000 309 (42) 19.4 2.10 (0.95–4.68) 0.069
$10,000 69 (12) 27.5 1.13 (0.24–5.40) 0.88
Note: PM=Placental malaria. OR=Odds ratio, CI=Confidence interval. P
a derived from multivariable logistic regression, controlling for gravidity, anti-malarial use during
third trimester, and malaria transmission season. Similar to previous analysis the reference group was selected based on the group with highest frequency for the
significant gene pair and based on the absence for significant individual gene.
False Discovery Rate (FDR) was used to correct P-values.
‘*’signifies uncorrected P-value that is ,0.05 but is non-significant after correction.
‘**’signifies uncorrected P-value that is significant after correction.
doi:10.1371/journal.pone.0038617.t004
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In this study, we identified associations between KIR2DL1,
KIR2DL2, and KIR2DL3 genes and PM infection. The data
shows that in HIV-1 negative women, the presence of the
individual genes KIR2DL1 and KIR2DL3 increased the odds for
having PM. Further analysis of this group showed that KIR2DL2/
KIR2DL2 homozygotes were less likely to have PM (Tables 2 &
3). In contrast, amongst HIV-1 positive women, the presence of
individual KIR2DL3, but not individual KIR2DL1, was associ-
ated with protection from PM and the women with KIR2DL2/
KIR2DL2 homozygote were more likely to have PM (Tables 2 &
3). Furthermore, when the HIV-1 positive mothers were stratified
by CD4 counts, the reverse associations between KIR gene
polymorphism and PM remained only in the individuals with high
CD4 cell counts, but not in those with low CD4 cell counts.
Collectively, the results suggest that inhibitory KIR2DL2 and
KIR2DL3, which are alleles of the same locus, play a role in the
inverse effects on PM and PM/HIV co-infection, and the effect of
KIR gene content polymorphisms on PM in HIV-1 women is
dependent on high CD4 counts.
The fundamental differences in KIRs and their ligand
interaction between malaria and HIV infections and between
placental compartments and peripheral blood may explain the
results from the current genetic association study. Numerous
studies on HIV-1 infection have pointed out the role of the
interactions between inhibitory KIR genes and HLA class I
ligands in the susceptibility to HIV infection. However, consider-
ing the erythrocytes, host cells for malaria parasites, are deficient
in expression of HLA class I molecules, it is possible that novel
ligands are involved in KIR’s recognition and regulatory role in
PM infection. It has been shown that malaria parasite infected
erythrocytes (IEs) bind directly to NK cells, by attaching P.
falciparum erythrocyte membrane protein-1 (pfEMP1) on IEs acting
as a ligand to chondroitin sulfate A (CSA) on the NK cells [56];
however the binding of IEs on its own does not activate the NK
cells [56]. Other studies reported that early NK cell derived IFN-c
response is absolutely dependent upon the contact with IEs and
the cytokine production by accessory cells (monocytes and myeloid
dendritic cells) [57]. Importantly, this ability of NK cells to react to
the accessory cell-derived cytokines is dictated by the KIR
genotype [58]. Taken together, this explains that the KIR without
HLA class I ligand could operate independently, leading to
protection (KIR2DL2) against or susceptibility (KIR2DL3 and
KIR2DL1) to malaria infection in HIV-1 negative women,
possibly by the binding of pfEMP1 on IEs to CSA on NK cells
and the cross talking between accessory cells and NK cells.
Alternatively, it is also possible that placental compartment has a
unique KIR-ligand recognition. Sequestration of malaria parasites
in the placenta is mediated by the cytoadherence of pfEMP1 on
IEs to CSA expressed on placental syncytiotrophoblast [2].
PfEMP1 is known to be highly diverse and a recent study
conducted in Kenya reported significant sequence variations in the
placental parasite specific pfEMP1 [59,60]. It is also known that
placental trophoblast is skewed towards the production of HLA-C,
the ligand for KIR2DL1, KIR2DL2 and KIR2DL3 expressed on
decidual NK cells. We, therefore, speculate that the cytoadherence
of the polymorphic placental malaria specific pfEMP1 to
trophoblasts could regulate HLA-C expression level in the
placenta according to the specific variation of pfEMP1, thus
affecting the binding of HLA-C to KIR2DL2 or KIR2DL3 and
KIR2DL1 in different ways. However, this hypothesis while
plausible needs to be tested. A previous report showed that
placental malaria infection decreased expression of HLA-G, a
non-classical MHC class I molecule, in trophoblast [61].
HIV status appeared to modify the effect of KIRs on PM,
reversing the association between the same set of KIR genes and
PM infection. Although the underlying functional mechanisms for
this switch remains unclear, broadly it is likely that a combination
of HIV-specific KIRs and their ligand interactions and other non-
genetic factors due to HIV-1 infection may drive the inversion of
the association between KIR gene content polymorphisms and
PM infection. Previous studies reported that gene content
polymorphism of KIR2DL2 and KIR2DL3 in relation to HLA-
C ligand controls the susceptibility to HIV infection in sex workers
and in perinatal transmission model [38,62]. It is possible that the
interactions of KIR2DL2/2DL3 with its ligands which are specific
for HIV may modify the relationship between KIR and PM and
that this modification could be mediated by quantitative alteration
of cellular expression of HLA class I ligands on T cells by HIV
virus, thus reversing the association between KIR2DL2/
Table 5. Linkage disequilibrium (LD) for pairs of KIR genes in HIV-1 negative and HIV-1 positive women, by placental malaria (PM)
Status.
KIR2DL2 KIR2DL3 KIR2DS2
HIV+ HIV2 African* HIV+ HIV2 African* HIV+ HIV African*
PM2 PM+ PM2 PM+ PM2 PM+ PM2 PM+ PM2 PM+ PM2 PM+
KIR2DL1 D 20.0130 20.0160 20.0280 – 20.1900 0.0180 0.0290 0.0540 – 0.2100 20.0150 20.0100 20.0330 – 20.3400
D92 1.0000 21.0000 21.0000 – 0.7720 1.0000 1.0000 – 21.0000 20.5050 21.0000 –
p 0.0020 0.0830 0.0280 – ,0.0001 0.0001 0.0004 0.0001 – ,0.0001 0.0002 0.2990 0.0110 – ,0.0001
KIR2DL2 D 20.0570 20.1040 20.0690 20.0220 20.2700 0.1930 0.1980 0.1910 0.1930 0.1600
D92 0.9550 21.0000 21.0000 21.0000 0.9230 0.9540 0.8990 0.9570
p 0.0001 0.0001 0.0001 0.0200 ,0.0001 0.0001 0.0001 0.0001 0.0001 0.0100
KIR2DL3 D 20.0540 20.0870 20.0820 20.0260 20.2800
D9 20.7710 20.6950 21.0000 21.0000
p 0.0001 0.0001 0.0001 0.0050 ,0.0001
Classical coefficient D measures deviation from random association between the gene pairs, and D9 is given by D with the maximum value it can have [54]. ‘–’ denotes D
value not determined due to monomorphism in one gene. LD was significant at P,0.002. African* is linkage disequilibrium cited from a previous population study [49].
doi:10.1371/journal.pone.0038617.t005
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supported by the studies that have described the selective down-
regulation of HLA class I ligands (including HLA-C) expression on
T cells by HIV virus [63]. Interestingly, another earlier study
reported an induced expression of HLA class I molecules on
erythrocytes in patients with HIV infection due to the effect of
increased endogenous production of interferon-a [64]; thus
supporting a possible interaction between the induced HLA class
I molecules on infected erythrocytes and KIR on NK cells in
malaria co-infection with HIV; however, this hypothesis needs to
be further tested.
In HIV infection, depletion and functional impairment of
CD4+ T cells is a key marker indicating progression to immuno-
compromised status, where the host could be rendered more
susceptible to malaria, tuberculosis and other opportunistic
infections [65,66,67]. Thus, HIV infected individuals with high
CD4 counts presumably have a better general immune capacity
including the immune regulatory functions compared to those with
low CD4 counts. In the present study, when we further stratified
HIV-1 positive women by CD4 counts we observed the association
of the KIR gene polymorphism with PM infection only in the
individuals with high CD4 cell counts but not those with low CD4
counts (Table 4). This result could be expected when considering
CD4 T cells as a marker for general immune status and KIRs as
an immune regulator. HIV positive women with high CD4 counts
maintain their general immune capacity including KIR regulatory
role; as such, the undamaged KIR regulatory function in these
women with different KIR genetic backgrounds could then
regulate immune effectors (such as NK cells) that further
determine their susceptibility to PM infection. In contrast, the
women with low CD4 counts, even with different KIR genetic
backgrounds, could lose their general immune capacity including
KIR regulatory function; thus no association between KIR gene
polymorphisms and PM could be predicted in this group.
Although the immune functional pathways involved in this process
are still unknown, a previous study has shown that there is a
difference in HLA class I alleles expression, ligands for KIRs,
between individuals with low and high CD4+ T cell counts [68].
In this study, we also further conducted the pair-wise LD
analysis for PM-relevant KIR2DL1, KIR2DL2 and KIR2DL3 as
well as KIR2DS2 and assessed the associations in the haplotype B
subtypes. Four gene pairs (KIR2DL1/KIR2DL3, KIR2DL2/
KIR2DS2, KIR2DL2/KIR2DL3 and KIR2DL3/KIR2DS2)
were in significant LD in HIV-1 positive women regardless of
PM status whereas only one gene pair KIR2DL2/KIR2DS2 was
in significant LD in HIV-1 negative women. Most importantly, we
further found that the four gene pairs, KIR2DL1/KIR2DL2 and
KIR2DL1/KIR2DS2 (HIV-1 positive) and KIR2DL2/KIR2DL3
and KIR2DL3/KIR2DS2 (HIV-1 negative), were in significant
LDs in the women without PM, consistent with LDs in the general
African populations [49]. However, the findings of the disruption
of LDs for these four respective pairs in the women with PM and
the high proportion of women with all three 2DL3, 2DL2 and
2DS2 present together (subtype B3) in the study population, are
unusual. Previous studies report the KIR2DL2/KIR2DL3 pair is
usually in complete negative LD while KIR2DS2, where present,
always pairs with KIR2DL2 [25,46,48]. In contrast, other studies
show the occurrence of the three gene pairs together (with no
report of disease association) [49,69,70], or break of LD associated
with disease [36]. Gene pairs showing strong LD indicate non-
random association at the population level and the observed
disruption in LDs associated with PM in this study suggests
possible selection by malaria infection. It has been suggested that
KIR are probably under strong selective pressure due to the
influence of pathogens [27] and many studies show that malaria
has a strong selection pressure on human genes [55]. In addition,
the disruption of LDs for different gene pairs could also partly
explain the opposite associations between KIR and PM in HIV-1
negative and positive women.
Lastly, the association between the secondary outcomes
(parasite density, anemia, pre-term delivery, and low birth weight)
and KIR gene content polymorphisms was also analyzed. We only
observed that HIV-1 negative women with subtype B1
(KIR2DS2-, KIR2DL2, and KIR2DL3+) were less likely to be
anemic (data not shown). At the moment, the actual mechanism
by which subtype B1 would regulate anemia in pregnant women is
still unknown. However, the genotype AA which is the opposite to
B1 subtype has been linked to predisposition to preeclampsia and
recurrent miscarriages [34,35], and there is an overlap of
symptoms between placental malaria and preeclampsia [71].
Thus, KIR might play a role in regulating these symptoms, one of
which is anemia.
To our knowledge, this is the first study to demonstrate an
association of KIR gene content polymorphisms with PM infection
in pregnant women with or without HIV-1 co-infection. Our study
is complex and makes use of mother samples from a PM/HIV
interaction epidemiological study with good clinical data. The
results suggest that inhibitory KIR2DL2 and KIR2DL3, which
are alleles of the same locus, play a role in the inverse effects on
PM alone and PM/HIV co-infection and the effect of KIR gene
content polymorphisms on PM in HIV-1 positive women is
dependent on high CD4 cell counts. In addition, the results from
our study suggest that anemia during pregnancy might be
regulated by KIR genes, and malaria infection could have a
selective pressure on KIR2DL2, KIR2DL3 and other relevant
KIR genes. Our results stress the need to further type the KIR
allele diversity in pregnant women and investigate KIR and novel
ligand binding in order to dissect the underlying mechanisms of
KIR recognition with and without HLA-class I involvement in
placental malaria infection. Further investigations are also
warranted in other malaria endemic regions to assess the effects
of racial differences, transmission intensities, and other environ-
mental factors on the interaction between KIR genes and
placental malaria.
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